The Standard of Care for Evaluating Metastatic Risk in Your Newly Diagnosed Uveal Melanoma Patients

The Standard of Care for Evaluating Metastatic Risk in Your Newly Diagnosed Uveal Melanoma Patients

Dx-UM

DecisionDx®-UM Overview

Genomic testing with DecisionDx-UM enables accurate assessment of metastatic risk.

Clinical Validation

DecisionDx-UM is extensively researched including multiple prospective studies.

Test Process

Learn more about the straightforward ordering process for DecisionDx-UM.

Scientific References

DecisionDx-UM is supported by 19 peer-reviewed publications.

Resources

A broad range of resources are available to support the use of DecisionDx-UM.

Additional Uveal Melanoma Tests

Additional DecisionDx tests designed to improve the treatment and management of uveal melanoma​.

Scroll to Top